Summary
Gender surgeons who attended WPATH and USPATH conferences (meetings of trans health professionals) were asked how many patients they had seen who regretted surgery or wanted it reversed. Fewer than a third replied. Together they recalled 62 such patients out of an estimated 18,000 to 27,000 they had operated on, so the authors put regret at 0.2–0.3%. Where reasons were known, the most common was a change in gender identity or a wrong diagnosis, then family or social rejection, then relationship problems. The authors suggest sorting regret into three types: 'true gender-related', 'social' and 'medical'. This grouping is useful for discussion. But the regret figure cannot be trusted: it depends on surgeons' memory, on regretful patients going back to a surgeon, and on numbers from a self-selected minority who answered.
Key findings
- Atsakė 46 iš 154 pakviestų chirurgų (30 %); dauguma dirbo JAV (67 %) arba Europoje (22 %), o 65 % praktikavo daugiau nei 10 metų.
- Jie apskaičiavo operavę 18 125–27 325 trans pacientus ir prisiminė 62, kurie gailėjosi operacijos ar prašė ją atšaukti – maždaug 0,2–0,3 %.
- 57 % chirurgų yra matę bent vieną besigailintį pacientą; 45 iš 62 atvejų (73 %) buvo susiję su lytinių organų operacija, o 13 (21 %) – su krūtinės ar krūtų operacija.
- Kai priežastys buvo žinomos (46 pacientai), 42 % atvejų susiję su lytinės tapatybės pasikeitimu ar klaidinga diagnoze, 15 % – su šeimos ar visuomenės atstūmimu, o 11 % – su santykių problemomis.
- Autoriai atšaukimo prašymus suskirstė į „tikrą su gender susijusį“ pasigailėjimą (42 %), „socialinį“ pasigailėjimą (37 %) ir „medicininį“ pasigailėjimą (8 %); 24 % šių pacientų po operacijos kilo komplikacijų.
- 91 % chirurgų prieš atšaukimo operaciją reikalautų naujo psichikos sveikatos vertinimo, o 88 % norėjo, kad kitose WPATH gairėse būtų aptartos atšaukimo operacijos.
- Autoriai pripažįsta, kad apklausos prastai tinka nustatyti, kaip dažnas koks nors reiškinys, ir kad ankstesnių tyrimų apžvalga nebuvo sisteminė.
Abstract
Background: A rare, but consequential, risk of gender affirming surgery (GAS) is post-operative regret resulting in a request for surgical reversal. Studies on regret and surgical reversal are scarce, and there is no standard terminology regarding either etiology and/or classification of the various forms of regret. This study includes a survey of surgeons' experience with patient regret and requests for reversal surgery, a literature review on the topic of regret, and expert, consensus opinion designed to establish a classification system for the etiology and types of regret experienced by some patients.
Methods: This anonymous survey was sent to the 154 surgeons who registered for the 2016 World Professional Association for Transgender Health (WPATH) conference and the 2017 USPATH conference. Responses were analyzed using descriptive statistics. A MeSH search of the gender-affirming outcomes literature was performed on PubMed for relevant studies pertaining to regret. Original research and review studies that were thought to discuss regret were included for full text review.
Results: The literature is inconsistent regarding etiology and classification of regret following GAS. Of the 154 surgeons queried, 30% responded to our survey. Cumulatively, these respondents treated between 18,125 and 27,325 individuals. Fifty-seven percent of surgeons encountered at least one patient who expressed regret, with a total of 62 patients expressing regret (0.2-0.3%). Etiologies of regret were varied and classified as either: (I) true gender-related regret (42%), (II) social regret (37%), and (III) medical regret (8%). The surgeons' experience with patient regret and request for reversal was consistent with the existing literature.
Conclusions: In this study, regret following GAS was rare and was consistent with the existing literature. Regret can be classified as true gender-related regret, social regret and medical regret resulting from complications, function, pre-intervention decision making. Guidelines in transgender health should offer preventive strategies as well as treatment recommendations, should a patient experience regret. Future studies and scientific discourse are encouraged on this important topic.
Conclusion
In this study, regret following GAS was rare and was consistent with the existing literature. Regret can be classified as true gender-related regret, social regret and medical regret resulting from complications, function, pre-intervention decision making. Guidelines in transgender health should offer preventive strategies as well as treatment recommendations, should a patient experience regret. Future studies and scientific discourse are encouraged on this important topic.